Patients with idiopathic pulmonary arterial hypertension (PAH) who responded to an acute vasodilator challenge — a clinical test that can…
Articles by admin
Initial results are now available from a national registry that has been established in Russia to track individuals with…
Pulmonary arterial hypertension (PAH) Â is a rare condition characterized by high blood pressure of the lung arteries. It costs…
A nursing researcher at Louisiana State University Health Sciences Center School of Nursing in New Orleans has found that…
An international collaboration of researchers from the United States and China reported that adiponectin (APN), a protein that regulates…
On Dec 10, 2014 iBio, Inc. revealed progress in developing IBIO-CFB03, a treatment for idiopathic pulmonary fibrosis (IPF), systemic sclerosis…
A research group from New York Medical College has found a gene that may control pulmonary hypertension severity, as…
The Pulmonary Fibrosis Foundation (PFF) and the U.S. Food And Drug Administration will discuss data from a…
The Coalition for Pulmonary Fibrosis (CPF), which has chosen September as National Pulmonary Fibrosis Month, recently announced…
Every Breath Counts: Idiopathic Pulmonary Fibrosis, a documentary to mark Pulmonary Fibrosis Awareness Month, will air on the Discovery…
Pulmonary Arterial Hypertension (PAH)Â is a life-threatening disease in which endothelial dysfunction, vasoconstriction in small pulmonary arteries, dysregulated proliferation of…
Pulmonary hypertension is a condition caused by increased pressure in the pulmonary arteries. In advanced cases, its symptoms (shortness…